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Abstract (word count: 266) 
 
Context. Tracheotomy is used to replace endotracheal intubation in patients requiring 
prolonged ventilation. However, there is considerable variability in the time 
considered optimal for performing tracheotomy. This is of clinical importance because 
(a) timing is a key criterion for performing a tracheotomy; (b) patients who have a 
tracheotomy use a large amount of resources. 
Objective. To determine the effectiveness of early tracheotomy (after 6-8 days of 
laryngeal intubation) compared to late tracheotomy (13-15 days of laryngeal 
intubation) in reducing the incidence of pneumonia and increasing the number of 
ventilator- and ICU-free days. 
Design, setting, and patients. Randomized clinical trial performed in 12 Italian ICUs 
from June 2004 to June 2008 that included 600 adult patients without lung infection 
who had been ventilated for 24 hours and had a Simplified Acute Physiology Score II 
between 35 and 65, and a sequential organ failure assessment score ≥ 5. 
Interventions. Patients who showed, 48 hours after inclusion: (a) worsening of 
respiratory conditions; (b) unchanged or worse sequential organ failure assessment 
score; and (c) no pneumonia were randomized to early (N=209) or late (N=210) 
tracheotomy.  Patients that received a tracheotomy after randomization were 145 in the 
early and 119 in the late group. 
Main Outcome Measures. Primary end-point was incidence of ventilator-acquired 
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pneumonia. 
Results. Ventilator-acquired pneumonia in the early and late groups was observed in 
30 (14%, 95% confidence interval 10 to 19%) and 44 (21%, 95% confidence interval 
15 to 26%) patients, respectively (P=0.073).   
Conclusion.  Among mechanically ventilated adult ICU patients, early tracheotomy 
compared to late tracheotomy did not result in statistically significant improvement in 
incidence of ventilator-acquired pneumonia. 
Trial Registration:  ClinicalTrials.gov: NCT00262431 
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Introduction  
Tracheotomy is a surgical procedure that is performed to replace endotracheal 
intubation in patients who are expected to require prolonged mechanical ventilation.1 
Advantages of tracheotomy include prevention of ventilator-acquired pneumonia 
(VAP), earlier weaning from respiratory support, and reduction in sedative use.2-5 
Although in recent years the use of tracheotomy has increased by nearly 200%,6 
analysis of a large database showed considerable variation in the timing of 
tracheotomy and in the incidence of tracheotomy.7 This observation is of clinical 
importance because (a) timing is an important criterion for tracheotomy, as many 
clinicians perform a tracheotomy based on identification of a specific time window;8 
(b) tracheotomy is associated with high resource use.9 
 
A consensus conference recommended performing tracheotomy after 3 weeks of 
endotracheal intubation.10 Although this time-scale for tracheotomy is widely used,11,12 
observational studies have reported that earlier tracheotomy may be associated with 
quicker weaning from mechanical ventilation.13,14 However, randomized clinical trials 
have failed to confirm this observation.  Rumbak and coworkers showed that 
tracheotomy within 2 days of admission reduced mortality rate, occurrence of 
pneumonia, and intensive care unit (ICU) length of stay compared to tracheotomy 
performed after 14-16 days of endotracheal intubation15. Blot and coworkers showed 
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that mortality, duration of mechanical ventilation and ICU stay, and incidence of 
infections did not differ between patients randomized to receive a tracheotomy within 
4 days following onset of mechanical ventilation and those randomized to maintain 
endotracheal intubation for at least 14 days.16 
 
We examined the hypothesis that tracheotomy performed after 6-8 days of 
endotracheal intubation compared to tracheotomy performed after 13-15 days of 
endotracheal intubation would reduce incidence of VAP. 
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Methods  
From June 2004 to June 2008, patients were recruited from 12 Italian ICUs.  
Review boards approved the protocol, and written consent was obtained from 
competent patients.  In incompetent patients, consent was issued from the referring 
physician (not involved in the study) and the family.17 
 
Patients were enrolled in the study if they: (a) were older than 18 years of age; 
(b) had been mechanically ventilated for acute respiratory failure for 24 hours; (c) had 
a Simplified Acute Physiology Score II (SAPS) between 35 and 65;18 (d) had a 
sequential organ failure assessment (SOFA) score equal to or greater than 5;19 (e) did 
not have pulmonary infection, as estimated by a Clinical Pulmonary Infection Score 
(CPIS) score less than 6.20, 21 Patients were not enrolled if they had: (a) chronic 
obstructive pulmonary disease; (b) anatomical deformity of the neck including 
thyromegaly and cervical tumors; (c) history of esophageal/tracheal or pulmonary 
cancer; (d) previous tracheotomy; (e) soft tissue infection of the neck; (d) 
hematological malignancy; (e) pregnancy.  
Forty-eight hours after enrollment, patients were randomized to receive a 
tracheotomy after 6-8 days of endotracheal intubation (early) or after 13-15 days of 
endotracheal intubation (late) if: a) the arterial oxygen pressure (PaO2) was less than 
or equal to 60 mmHg with a fraction of inspiratory oxygen (FiO2) of at least 0.5 and a 
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positive end-expiratory pressure (PEEP) of at least 8 cmH2O; b) an attending clinician 
not involved in the study considered that the acute clinical condition requiring 
ventilatory support was still unresolved; and c) the SOFA score remained equal to or 
greater than 5.19 Patients were not randomized if there was: (a) improvement in 
respiratory conditions identified as a PaO2 greater than 60 mmHg with a FiO2 less than 
50% and PEEP less than 8 cmH2O and the attending clinician considered that the acute 
clinical condition requiring mechanical ventilation had resolved; (b) pulmonary 
infection as estimated by a Clinical Pulmonary Infection Score (CPIS) score greater 
than 6;20, 21 (c) moribund state or death.   
Tracheotomy was not performed if one of the following a priori defined 
conditions occurred: (a) improvement in oxygenation, identified as a PaO2 greater than 
60 mmHg with a FiO2 less than 50% and PEEP less than 8 cmH2O and the attending 
clinician considered that the acute clinical condition requiring mechanical ventilation 
had resolved; (b) moribund state or death; (c) intra-cranial pressure greater than 15 
mmHg and/or cerebral perfusion pressure less than 60 mmHg;22 (d) platelet count less 
than or equal to 50,000/mm3, activated partial thromboplastin time or prothrombin 
time longer than 1.5 seconds, or bleeding time greater than twice normal in the 24 
hour prior to the scheduled tracheotomy. Patients randomized to early or late that did 
not receive the planned tracheotomy were still included in the final analysis due to the 
intention-to-treat design. 
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Adverse events associated to tracheotomy were classified as “intra-operative” 
(minor bleeding i.e. bleeding that could be controlled by digital pressure, significant 
bleeding i.e. any bleeding event that required the administration of 1 unit of packed 
red cells, difficult tracheotomy tube placement, i.e. requiring more than 2 attempts at 
insertion during primary placement procedure, hypoxemia i.e. oxygen saturation of < 
90% for > 90 seconds, arrhythmia, cardiac arrest) and “post-operative” (stoma 
inflammation, stoma infection, minor bleeding, major bleeding, pneumothorax, 
subcutaneous emphysema, tracheo-esophageal fistula, cannula displacement or need 
for cannula replacement) and their occurrence recorded during the 28-days study 
period.23 
The presence of VAP was defined using the simplified Clinical Pulmonary 
Infection Score (CPIS) score.21 A score of 0, 1 or 2 is given for tracheal secretions, 
chest X-ray infiltrates, temperature, leukocyte count, and of 0 or 2 for PaO2/FiO2 (or 
evidence of acute respiratory distress syndrome: ARDS) and microbiology21.  A CPIS 
greater than 6 was considered to indicate the presence of VAP.21, 24 The score was 
calculated on study entry, immediately before randomization, and every 72 hours till 
day 28 from randomization.19 The CPIS score was also evaluated before performing 
scheduled tracheotomy.  A clinician blinded to patient allocation that looked at clinical 
charts remotely and not seeing the patient evaluated the non-objective components of 
the CPIS score (quality of secretions, chest X-ray, evidence of ARDS).  The SOFA 
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score was calculated using the most abnormal value for each of the six organ systems 
and was calculated on admission and before randomization. 
 
The primary outcome variable was the 28-day cumulative incidence of VAP 
calculated from the date of randomization. Secondary outcome variables were: (a) 
number of ventilator-free days during the 28 days immediately after randomization, 
calculated from the date of randomization to the date of the first period of spontaneous 
breathing that lasted at least 48 consecutive hours;25 (b) number of ICU-free days 
during the 28 days immediately after randomization, calculated from the date of 
randomization to the date of an ICU discharge; (c) number of patients in each group 
who were alive during the 28 days immediately after randomization.  Long-term 
outcome was evaluated in the two groups as hospital length of stay, and need after 
hospital discharge of long term care facility.  Mortality at one year from randomization 
was evaluated trying to contact all study patients who had been discharged alive from 
hospitals.    
To limit effects of management heterogeneity among centers on outcome 
variables, all patients were placed in the semi-recumbent position,26, 27 and weaning 
from mechanical ventilation28 and use of sedatives and analgesics29 were constrained 
by protocols. The choice of technique and the location for tracheotomy (bedside 
versus operating room) were not protocol controlled.  
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Concealed randomization was conducted centrally using a computer-generated 
randomization schedule. Based on previous data,30 the predicted incidence of VAP 
was 30%.  The trial was designed to enroll 320 patients in order to demonstrate a 35 % 
relative reduction in VAP (from 30 % to 20 %) with an alpha of 0.05 and a power of 
80% assuming that some of the subjects randomized to each group could not actually 
receive a tracheotomy.  All analyses were conducted on an intension-to-treat basis. 
Values are reported as mean (standard deviation) or median (interquartile range). 
Comparisons between groups (early vs. late) and between different study times were 
conducted using chi-squared test, Fisher’s exact test, paired and unpaired two-tailed T- 
test and Wilcoxon’s test.  Kaplan-Meier curves were compared by the log-rank test; 
cumulative incidence of VAP was compared by Gray’s test31 considering death as a 
competing event32.  Hazard ratios were calculated using Cox and Fine & Gray models; 
proportional hazards assumption for the use of these models was evaluate by graphic 
evaluation of scaled Schoenfeld-Type residuals.  A probability of 0.05 on two-sided 
testing was regarded as significant (STATA 9.2; STATA Corp, Texas and R 2.5.0, 
package cmprsk; open source).  
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Results 
Of the 600 enrolled patients, 419 patients were randomized to receive an early 
(N=209) or a late (N=210) tracheotomy. The remaining 181 patients were not 
randomized because of improvement in respiratory conditions (N=92), occurrence of 
pulmonary infection (N=24), and moribund state or death (N=65). Of the 209 patients 
randomized to the early group, 145 patients received a tracheotomy after 7 (1) days of 
endotracheal intubation.  Of the 210 patients randomized to the late group, 119 
patients received a tracheotomy after 14 (1) days of endotracheal intubation (Figure 
1). Analyses were conducted on the intention-to-treat population of 419 patients.  
 Baseline characteristics at admission or before randomization did not differ 
between the two groups.  At randomization, type of admission was medical (40 vs. 36 
%), for scheduled surgery (8 vs. 10 %) and unscheduled surgery (41 vs. 45 %), and 
trauma (11 vs. 9 %) in the early and late group, respectively.  At randomization, the 
SOFA score increased and oxygenation parameters significantly worsened in both 
groups (Table 1). 
All tracheotomy were performed at the bedside using percutaneous techniques33 
(“Griggs” technique34 in the 72% of early and 73% of late and “percutwist” 
technique35 in the 25% of early and 22% of late).  Adverse events associated to 
tracheotomy are indicated in Table 2.  Thirty-nine % of the patients in both group (57 
patients in early and 46 patients in late group) experienced an adverse effect. 
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Figure 2 shows the Kaplan-Meier curves for cumulative incidence of VAP 
according to whether patients were randomized to early or late tracheotomy.  VAP was 
observed in 30 patients in the early group (14%, 95% confidence interval 10 to19%) 
and in 44 patients in the late group (21%, 95% confidence interval 15 to 26%) 
(P=0.073).   
The numbers of ventilator- and ICU-free days and the incidence of successful 
weaning and of ICU discharge were significantly greater in patients randomized to 
early tracheotomy than in patients randomized to late tracheotomy; there were no 
differences between the groups in survival at 28 days (Table 3). Hazard ratio and 95% 
confidence interval of developing VAP, of remaining connected to the ventilator, of 
remaining in the ICU and of dying were 0.66 (0.42 to 1.04), 0.70 (0.56 to 0.87), 0.73 
(0.55 to 0.97), 0.80 (0.56 to 1.15), respectively.  
Median and interquartile range of the hospital length of stay was 31 (17-49) and 
32 (18-59) days in early and late, respectively.  Data on mortality at one year and need 
of long-term care facility were obtained in 292 of the patients that left the hospital 
alive (144 in the early group and 148 patients in the late group).  Survival at one year 
was 50% (72 patients; confidence interval: 41 to 61%) in the early group and 43% (63 
patients; confidence interval: 34 to 52%) in the late group (P=0.248).  Admission to 
long-term care facility was required by the 39% (56 patients) in the early and in the 
36% (53 patients) in the late (P=0.915). 
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Discussion 
The present study shows that tracheotomy performed after 6-8 days of 
endotracheal intubation did not result in a reduced incidence of VAP compared with 
tracheotomy performed after 13-15 days of endotracheal intubation.   
 
Prolonged endotracheal intubation is known to be associated with airway tissue 
trauma, infection, patient discomfort, and need for high doses of sedation.36,37 
Tracheotomy, the procedure that creates temporary or persistent access to the trachea, 
is commonly performed to replace endotracheal intubation in ICU patients who are 
expected to require prolonged mechanical ventilation3,4 since provides an access to the 
airway that is more stable and better tolerated than endotracheal intubation and that 
facilitates toilet of pulmonary secretions, oral feeding, and patient communication.3,4,38 
The National Association of Medical Directors of Respiratory Care recommended that 
tracheotomy should replace endotracheal intubation in patients who still require 
mechanical ventilation 3 weeks after admission and noted that identification of the 
optimal time for a tracheotomy to be performed is one of the most important criteria 
when deciding to perform a tracheotomy.10 Introduction of percutaneous tracheotomy 
techniques into clinical practice39 has made tracheotomy possible at the bedside 
without need for surgeons or operating room23 and increased use of tracheotomy in the 
ICU by nearly 200%.6  
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Analysis of the US National Trauma Databank showed that the rates and timing 
of tracheotomy varied significantly across ICUs.7 A preconceived notion of efficacy in 
the absence of any evidence to support an optimal time for a tracheotomy has been 
advocated to explain this discrepancy between the wide use of tracheotomy on the one 
hand and its inconsistent and non-homogenous clinical use on the other.38 This may be 
of particular clinical importance since patients receiving a tracheotomy represent a 
cohort which is among the most resource intensive to provide care for.9,14,40 
 
A prospective randomized trial that included 120 patients reported that performing 
tracheotomy within 2 days of admission was associated with a halving of 30-day 
mortality rate, a reduced occurrence of pneumonia, and a shortened ICU length of stay 
compared to performing tracheotomy within 14-16 days of admission.15 A later meta-
analysis noted that performing a tracheotomy up to 7 days after initiation of 
endotracheal intubation shortened the duration of mechanical ventilation and length of 
stay in intensive care but did not affect outcome compared to later tracheotomy.41 A 
more recent clinical trial that included 123 patients showed that mortality, duration of 
mechanical ventilation, duration of ICU stay, and incidence of infections did not differ 
between patients randomized to receive a tracheotomy within 4 days following onset 
of mechanical ventilation and those in whom endotracheal intubation was maintained 
for at least 14 days.16 
The present study estimated the need for prolonged ventilation by (a) severity of 
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illness and (b) need for ventilatory support required to obtain pre-defined oxygenation 
criteria. These criteria selected patients who at study enrollment had a SAPS II score 
of 50.8 (8.2) and at randomization had an increase in SOFA score and a worsening in 
respiratory parameters.  Ferreira recently demonstrated that mortality in patients 
matching these criteria ranged between 35 and 40%.19 Under these circumstances and 
in contrast to previous trials,15,16,41 almost two thirds of the screened patients were 
randomized and underwent the scheduled tracheotomy.  Patients who, although 
randomized did not actually receive a tracheotomy, were included in the final analysis 
because of the intention-to-treat design.   
We chose the 28-day cumulative incidence of VAP as the primary outcome 
variable.  Occurrence of VAP was evaluated with a score that combines objective 
(temperature, and PaO2/FiO2 values, leukocyte count, and microbiology findings) and 
non-objective (quality of secretions, chest X-ray interpretation, evidence of ARDS) 
components20,21,24.  To minimize the potential bias of the latter on evaluation of the 
primary outcome variable we had the non-objective components of the score evaluated 
by clinicians blinded to patient allocation and that looked at the clinical charts 
remotely and not seeing the patient.  
The incidence of VAP was 14% in the early group (30 patients; 95% confidence 
interval 10 to 19%) and 21% in the late group (44 patients; 95% confidence interval 15 
to 26%) (P=0.073).  This 33% risk reduction was therefore smaller than planned and 
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did not reach statistical significance because the observed incidence of VAP in the 
control group was less than that predicted.  Moreover, only 69 % of the patients 
randomized to early and 57 % of the patients randomized to late did receive the 
planned tracheotomy. 
Other possible explanation is that there is really no improvement from earlier 
tracheotomy.  Results of the present study show that while anticipating tracheotomy of 
one week decreased the need of ventilatory support and of ICU admission, planning an 
earlier tracheotomy actually (a) increased the number of patients that received a 
tracheotomy (69 % of the patients randomized to early received a tracheotomy while 
57 % of the patients randomized to late received a tracheotomy); (b) did not decrease 
the incidence of VAP; (c) did not influence hospital length of stay, mortality at one 
year and need of long-term health care facility; but (c) increased the number of 
patients potentially exposed to the adverse effects related to the tracheotomy.  
 
In conclusion our data show that, in intubated and mechanically ventilated adult 
ICU patients with a high mortality rate, tracheotomy performed after 6-8 days of 
endotracheal intubation did not result in a significant reduction in incidence of VAP 
compared to tracheotomy performed after 13-15 days of endotracheal intubation.  
Although the number of ICU and ventilator free days was higher in the former than in 
the latter, long-term outcome did not differ.  Considering that anticipation of 
tracheotomy of one week increased the number of patients that received a tracheotomy 
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and that more than one third of the patients experienced adverse effect related to the 
tracheotomy, these data suggest that tracheotomy should not be performed earlier than 
after 13-15 days of endotracheal intubation. 
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Figure Legends 
 
FIGURE 1.  Flow chart of the study protocol 
 
FIGURE 2.  Kaplan-Meier curves of development of VAP according to whether patients 
received an early or a late tracheotomy.   
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Table 1. Characteristics of the study population at enrollment and at randomization 
 
 
early tracheotomy
(n =209 ) 
late tracheotomy 
(n =210 ) 
AT ENROLLMENT   
Age, yrs 61.8  (17.4) 61.3 (16.8) 
Male, % [number] 66.0 [138] 67.6 [142] 
SAPS II score 51.1 (8.7) 49.7 (8.6) 
SOFA score 7.9 (2.6) 7.6 (2.9) 
PaO2, mmHg 123 (50) 123 (54) 
FiO2 0.52 (0.17) 0.53 (0.19) 
PEEP, cm H2O 6.1 (3.6) 6.6 (3.4) 
Primary organ failure, % (number)   
respiratory 45.9 [96] 47.1 [99] 
central nervous system 22.9 [48] 25.7 [54] 
cardiovascular 24.4 [51] 20.0 [42] 
renal 5.3 [11] 4.8 [10] 
coagulation 1.4 [3] 2.4 [5] 
AT RANDOMIZATION   
SOFA score 10.1 (1.3)° 9.8 (1.5)# 
PaO2 (mmHg) 76 (14)° 73 (13)* 
FiO2 0.64 (0.10)° 0.68 (0.11)* 
PEEP (cm H2O) 9.4 (1.2)* 9.3 (1.1)° 
Values are means (standard deviation). SAPS II represents simplified acute physiological score (range 0 
and 163) and is an index of the severity of illness; higher values indicate greater severity. SOFA represents 
sequential organ failure assessment score, and is an index of the extent of organ (respiratory, 
cardiovascular, hepatic, coagulation, renal and neurological systems) failure (range 0-24); higher values 
indicate greater severity of organ failure.  PaO2 is arterial oxygen.  FiO2 is inspiratory oxygen fraction 
ratio.  PEEP is positive end expiratory pressure.  ° P=0.04; * P=0.03;  # P=0.02 “AT RANDOMIZATION” 
vs. “AT ENROLLMENT” (paired two-tailed T- test or Wilcoxon’s test); all comparisons between early and 
late were not significant (chi-squared test, unpaired two-tailed T- test or Wilcoxon’s test). All P values are 
two-tailed.
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Table 2. Potential adverse events associated to tracheotomy in the early and late 
groups 
 
 early tracheotomy 
(n = 145 ) 
late tracheotomy 
(n =119 ) 
INTRA-OPERATIVE   
Minor bleeding, n 2 3 
Significant bleeding, n 0 0 
Tube dislocation, n 2 3 
hypoxemia, n 7 5 
arrhythmia, n 0 0 
cardiac arrest, n 0 0 
POST-OPERATIVE   
stoma inflammation, n 22 18 
stoma infection, n 9 7 
minor bleeding, n 8 6 
major bleeding, n 3 3 
pneumothorax, n 1 0 
subcutaneous emphysema, n 1 0 
tracheo-esophageal fistula, n 0 1 
cannula displacement or need for cannula replacement, n 2 0 
TOTAL, n (%) 57 (39) 46 (39) 
 
All differencs between early vs. late were not statistically significant (chi-squared test or  Fisher’s 
exact test). 
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Table 3.  Secondary end-points in the early and late tracheotomy groups 
 
 early tracheotomy 
(n =209 ) 
late tracheotomy 
(n =210 ) 
P 
    
Ventilator-free days at 28 days 
 
11 (0-21) 6 (0-17) 0.016 
    
ICU-free days at 28 days 
  
0 (0-13) 0 (0-8) 0.015 
Successful weaning, n (%) 161 (77) CI: 0.71 to 0.82 142 (68) (CI 0.61 to 0.74) 0.002 
ICU discharge, n (%) 101 (48) CI: 0.42 to 0.55) 82 (39) (CI: 0.32 to 0.46) 0.029 
Survival at 28 days, n (%) 154 (74) CI: 68 to 80 144 (68) CI: 63 to 75  0.248 
 
Data of ventilator-free days and ICU-free days are median and interquartile range;  
all P values are 2-tailed (Wilcoxon’s test, log-rank test and Gray’s test).  ICU 
stands for intensive care unit. CI stands for 95% confidence interval.   
 
 
 
 
